Dr Lulu Bravo : A New Dengue Vaccine

Gov't must set higher vaccination budget for elderly – health expert

Practice the 4S in Dengue Prevention and Control

Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults

6th Asia Dengue Summit Recordings

Making Vaccines About Science, Not Politics - Asian Scientist Magazine

Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003). - Abstract - Europe PMC

Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults

ISNTD UNGA75 Dengue Side meeting VACCINE HESITANCY, DENGUE & THE CASE FOR REBUILDING TRUST

World Dengue Day: A call for action

PH needs vaccine for dengue as disease remains a threat despite drop in cases

Pediatric Oncall

What happens when vaccine scepticism takes over? Look to the Philippines

What happens when vaccine scepticism takes over? Look to the Philippines

Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection